Verrica Pharmaceuticals I...

NASDAQ: VRCA · Real-Time Price · USD
6.20
0.05 (0.81%)
At close: Aug 15, 2025, 12:15 PM

Verrica Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-76.58M -67M -24.49M -35.08M
Depreciation & Amortization
1.27M 836K 718K 472K
Stock-Based Compensation
7.16M 14.38M 4.99M 6.05M
Other Working Capital
-1.74M 11.59M -1.46M -1.03M
Other Non-Cash Items
5.19M 3.35M 1.93M 1.44M
Deferred Income Tax
n/a n/a n/a 66K
Change in Working Capital
2.03M 9.86M -1.8M -535K
Operating Cash Flow
-60.93M -38.58M -18.65M -27.58M
Capital Expenditures
-27K -362K -302K -883K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -4.49M -68.91M
Sales Maturities Of Investments
n/a n/a 59.01M 69M
Other Investing Acitivies
8K n/a -180K -201K
Investing Cash Flow
-19K -362K 54.04M -998K
Debt Repayment
-2.06M 44.08M -43.75M 4.97M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
155K -169K -17K 558K
Financial Cash Flow
37.73M 74.21M -16.87M 33.65M
Net Cash Flow
-23.22M 35.27M 18.52M 5.07M
Free Cash Flow
-60.95M -38.94M -18.95M -28.46M